pembrolizumabpembrolizumab-treateddurvalumabLY2510924ICB-treatedAMD3100ICBBL-8040plerixaforCRC+1 more
…ssion quartiles in a subgroup of patients with CRC treated with pembrolizumab (n=500). The CXCR4high cohort showed significantly improved sur…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: LY2510924 ×
LY2510924
This drug is selected. Its supporting articles are shown below.